These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 788897

  • 1. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA, Kleinerman J, Saidel GM.
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [Abstract] [Full Text] [Related]

  • 2. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
    Bennett JA, Gruft H, McKneally MF, Zelterman D, Crispen RG.
    Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
    [Abstract] [Full Text] [Related]

  • 3. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
    Chou T, Bertera S, Chang AE, Shu S.
    J Immunol; 1988 Sep 01; 141(5):1775-81. PubMed ID: 3261761
    [Abstract] [Full Text] [Related]

  • 4. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB, Serrou B.
    Cancer Res; 1976 May 01; 36(5):1731-4. PubMed ID: 773530
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M, Lawrence N, Nisbet NW.
    Biomedicine; 1976 Jan 01; 24(1):26-31. PubMed ID: 773443
    [Abstract] [Full Text] [Related]

  • 6. Toxicity of intrapleural Bacillus Calmette-Guérin treatment in animals.
    Filardi MJ, Codish SD, Civerchia L, Howard RK, McKneally MF.
    Cancer Res; 1979 Sep 01; 39(9):3673-6. PubMed ID: 383285
    [Abstract] [Full Text] [Related]

  • 7. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [Abstract] [Full Text] [Related]

  • 8. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J, Bubeník J.
    Folia Biol (Praha); 1973 Dec 01; 19(4):296-300. PubMed ID: 4356560
    [No Abstract] [Full Text] [Related]

  • 9. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC, Breeding JH.
    Cancer Res; 1974 Dec 01; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma.
    Bast RC, Zbar B, Mackaness GB, Rapp HJ.
    J Natl Cancer Inst; 1975 Mar 01; 54(3):749-56. PubMed ID: 804566
    [Abstract] [Full Text] [Related]

  • 11. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul 01; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 12. A cytokinetic analysis of bacillus calmette-guérin-induced growth control of a murine leukemia.
    Olsson L, Mathé G.
    Cancer Res; 1977 Jun 01; 37(6):1743-9. PubMed ID: 322860
    [Abstract] [Full Text] [Related]

  • 13. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M.
    J Immunol; 1999 Mar 15; 162(6):3574-82. PubMed ID: 10092816
    [Abstract] [Full Text] [Related]

  • 14. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L, Hunter N, Withers HR.
    Cancer Res; 1974 Mar 15; 34(3):613-20. PubMed ID: 4590922
    [No Abstract] [Full Text] [Related]

  • 15. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
    Vonberg RP, Mueller M, Emmendoerffer A, Freihorst J.
    Clin Exp Med; 2005 Dec 15; 5(4):177-83. PubMed ID: 16362797
    [Abstract] [Full Text] [Related]

  • 16. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A, Ratliff TL, Oakley DM, Catalona WJ.
    Cancer Res; 1983 Apr 15; 43(4):1611-5. PubMed ID: 6339040
    [Abstract] [Full Text] [Related]

  • 17. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL, Rios A.
    Natl Cancer Inst Monogr; 1973 Dec 15; 39():57-68. PubMed ID: 4595327
    [No Abstract] [Full Text] [Related]

  • 18. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Namba M, Ogura T, Hirao F, Azuma I, Yamamura Y.
    Gan; 1978 Dec 15; 69(6):831-4. PubMed ID: 374173
    [Abstract] [Full Text] [Related]

  • 19. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ, Mulé JJ, Rosenberg SA.
    Cancer Res; 1986 Oct 15; 46(10):4973-8. PubMed ID: 3489517
    [Abstract] [Full Text] [Related]

  • 20. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb 15; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.